BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22175142)

  • 1. [Treatment of rheumatic diseases: current status and future prospective. Topics: III. Biological drugs; 4. Interleukin-1 inhibitor].
    Yamasaki S; Kawakami A
    Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2985-90. PubMed ID: 22175142
    [No Abstract]   [Full Text] [Related]  

  • 2. Cryopyrin-associated periodic syndrome in early childhood can be successfully treated with interleukin-1 blockades.
    Eskola V; Pohjankoski H; Kröger L; Aalto K; Latva K; Korppi M
    Acta Paediatr; 2018 Apr; 107(4):577-580. PubMed ID: 29331074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Treatment of CINCA/NOMID Syndrome with Interleukin-1 Blockade.
    Macejová Z; Vargová V; Matejka M; Szekanecz Z
    Isr Med Assoc J; 2015 Jun; 17(6):389-91. PubMed ID: 26234003
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-1 blockade in rheumatoid arthritis and heart failure: a missed opportunity?
    Abbate A; Canada JM; Van Tassell BW; Wise CM; Dinarello CA
    Int J Cardiol; 2014 Feb; 171(3):e125-6. PubMed ID: 24418290
    [No Abstract]   [Full Text] [Related]  

  • 5. [IL-1 antagonists].
    Kötter I; Horneff G
    Z Rheumatol; 2010 Sep; 69(7):581-93. PubMed ID: 20703489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Efficacy of Anakinra in Cryopyrin-Associated Periodic Syndrome: Focus on Destructive Arthropathy.
    Kim YH; Kim BJ; Han J; Choi BY; Lee S
    J Clin Immunol; 2021 Nov; 41(8):1936-1939. PubMed ID: 34346012
    [No Abstract]   [Full Text] [Related]  

  • 7. Anakinra efficacy in a Caucasian patient with renal AA amyloidosis secondary to cryopyrin-associated periodic syndrome.
    Aït-Abdesselam T; Lequerré T; Legallicier B; François A; Le Loët X; Vittecoq O
    Joint Bone Spine; 2010 Dec; 77(6):616-7. PubMed ID: 20609610
    [No Abstract]   [Full Text] [Related]  

  • 8. [Update in interleukin-1 inhibition].
    de Boysson H
    Rev Med Interne; 2012 Apr; 33(4):235-7. PubMed ID: 22360831
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term treatment with anakinra and canakinumab resolves patellar subchondral erosion in neonatal-onset multisystem inflammatory disease.
    Leone A; Manna R; Verrecchia E; Cipullo M; Rigante D
    Reumatismo; 2019 Apr; 71(1):53-55. PubMed ID: 30932446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muckle-Wells treatment with anakinra.
    Eungdamrong J; Boyd KP; Meehan SA; Latkowski JA
    Dermatol Online J; 2013 Dec; 19(12):20720. PubMed ID: 24365011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CAPS treatment].
    Jiménez Treviño S; Ramos Polo E
    Med Clin (Barc); 2011 Jan; 136 Suppl 1():29-33. PubMed ID: 21596184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interleukin-1 inhibitors: a new alternative for the treatment of rheumatoid polyarthritis].
    Gabay C
    Rev Med Suisse Romande; 2000 Jun; 120(6):529-33. PubMed ID: 11014098
    [No Abstract]   [Full Text] [Related]  

  • 13. Actual status of antiinterleukin-1 therapies in rheumatic diseases.
    Geyer M; Müller-Ladner U
    Curr Opin Rheumatol; 2010 May; 22(3):246-51. PubMed ID: 20150813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anakinra and its rapidly expanding role in management of nonarthritic systemic disorders.
    Kapoor S
    J Rheumatol; 2009 Feb; 36(2):446; author reply 447. PubMed ID: 19208574
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytokine blocker licensed for relief of rheumatoid arthritis symptoms.
    Am J Health Syst Pharm; 2002 Feb; 59(3):225-6. PubMed ID: 11862629
    [No Abstract]   [Full Text] [Related]  

  • 16. Cryopyrin-associated periodic syndrome.
    Giat E; Lidar M
    Isr Med Assoc J; 2014 Oct; 16(10):659-61. PubMed ID: 25438464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anakinra for cryopyrin-associated periodic syndrome.
    Koné-Paut I; Galeotti C
    Expert Rev Clin Immunol; 2014 Jan; 10(1):7-18. PubMed ID: 24308832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auto-Inflammatory Syndromes Revealing Hematological Disorders and Anakinra Efficacy in 2 Cases.
    Brevet P; Curie A; Princivil C; Zarnitsky C; Alcaix D
    J Clin Rheumatol; 2021 Dec; 27(8S):S403-S404. PubMed ID: 32496361
    [No Abstract]   [Full Text] [Related]  

  • 19. The Future of IL-1 Targeting in Kidney Disease.
    Afsar B; Covic A; Ortiz A; Afsar RE; Kanbay M
    Drugs; 2018 Jul; 78(11):1073-1083. PubMed ID: 29968152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal urticaria: Could it be CAPS?
    Cutts L; Parslew R; Eustace K
    Pediatr Dermatol; 2018 Nov; 35(6):e420-e421. PubMed ID: 30187963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.